Lavipharm S.A. (ATH:LAVI)
Greece · Delayed Price · Currency is EUR 1.482
-0.018 (-1.20%)
Nov 3, 2026, 4:56 PM EET
Lavipharm Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 253 | 164 | 134 | 134 | 64 | 30 | |
Market Cap Growth | 85.69% | 22.01% | 0.36% | 107.29% | 117.58% | 23.40% |
Enterprise Value | 291 | 191 | 157 | 161 | 98 | 66 |
Last Close Price | 1.50 | 0.96 | 0.76 | 0.77 | 0.37 | 1.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 45.13 | 27.34 | 14.93 | 71.42 | 77.29 | 17.20 |
PS Ratio | 3.64 | 2.62 | 2.53 | 2.79 | 1.65 | 0.75 |
PB Ratio | 4.55 | 2.90 | 2.53 | 3.12 | 1.60 | -2.98 |
P/TBV Ratio | 49.17 | 11.22 | 17.21 | 78.88 | - | - |
P/FCF Ratio | 43.53 | 30.35 | - | - | - | 13.52 |
P/OCF Ratio | 35.94 | 24.56 | 29.82 | 470.51 | 19.27 | 7.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.18 | 3.06 | 2.96 | 3.36 | 2.50 | 1.67 |
EV/EBITDA Ratio | 20.77 | 14.81 | 17.69 | 19.44 | 19.70 | 12.35 |
EV/EBIT Ratio | 32.64 | 22.18 | 31.17 | 34.11 | 24.01 | 14.66 |
EV/FCF Ratio | 49.93 | 35.47 | - | - | - | 30.17 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.73 | 0.58 | 0.64 | 0.76 | 0.92 | -3.76 |
Debt / EBITDA Ratio | 2.92 | 2.39 | 3.53 | 3.64 | 6.68 | 6.28 |
Debt / FCF Ratio | 7.01 | 6.08 | - | - | - | 17.03 |
Net Debt / Equity Ratio | 0.67 | 0.47 | 0.54 | 0.56 | 0.47 | -3.59 |
Net Debt / EBITDA Ratio | 2.81 | 2.07 | 3.20 | 2.91 | 3.82 | 6.66 |
Net Debt / FCF Ratio | 6.40 | 4.95 | -5.51 | -6.39 | -0.59 | 16.28 |
Asset Turnover | 0.53 | 0.49 | 0.44 | 0.42 | 0.47 | 0.77 |
Inventory Turnover | 1.57 | 1.49 | 1.52 | 1.93 | 2.18 | 2.70 |
Quick Ratio | 0.58 | 0.65 | 0.56 | 0.66 | 0.70 | 0.35 |
Current Ratio | 1.22 | 1.21 | 1.15 | 1.27 | 1.00 | 0.63 |
Return on Equity (ROE) | 10.22% | 9.23% | 18.10% | 4.74% | 6.25% | - |
Return on Assets (ROA) | 4.23% | 4.22% | 2.62% | 2.57% | 3.04% | 5.46% |
Return on Invested Capital (ROIC) | 7.49% | 7.06% | 6.79% | 4.58% | 4.82% | 13.08% |
Return on Capital Employed (ROCE) | 9.40% | 10.00% | 5.80% | 6.00% | 5.90% | 38.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.22% | 3.66% | 6.70% | 1.40% | 1.29% | 5.82% |
FCF Yield | 2.30% | 3.29% | -3.84% | -2.82% | -50.06% | 7.40% |
Dividend Yield | 1.35% | 2.07% | 2.52% | - | - | - |
Payout Ratio | 58.87% | 56.48% | - | - | - | - |
Buyback Yield / Dilution | -1.29% | 0.06% | -0.17% | -681.40% | -26.42% | - |
Total Shareholder Return | 0.06% | 2.12% | 2.34% | -681.40% | -26.42% | - |